Clinical Presentations and Outcomes of Patients Receiving Immune Checkpoint Inhibitors Presenting to the Emergency Department

Clinical Presentations and Outcomes of Patients Receiving Immune Checkpoint Inhibitors Presenting to the Emergency Department

Immune checkpoint inhibitors (ICIs) are increasingly used in the treatment of cancer. Immune checkpoint inhibitors may cause a wide-range of autoimmune toxicities referred to as immune-related adverse events (irAEs). There is a paucity of data regarding the presentations and outcomes of patients rec...

Full description

Bibliographic Details
Main Authors: Richmond M. Castillo, MD, Benjamin J. Sandefur, MD, Alexander S. Finch, MD, Michael D. Richter, MD, Uma Thanarajasingam, MD, PhD
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2542454821001508

Internet

http://www.sciencedirect.com/science/article/pii/S2542454821001508

Similar Items